<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    ijoc
   </journal-id>
   <journal-title-group>
    <journal-title>
     International Journal of Organic Chemistry
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2161-4687
   </issn>
   <issn publication-format="print">
    2161-4695
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/ijoc.2024.144008
   </article-id>
   <article-id pub-id-type="publisher-id">
    ijoc-138338
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Biomedical 
     </subject>
     <subject>
       Life Sciences, Chemistry 
     </subject>
     <subject>
       Materials Science
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    A New Process of Synthesizing Anandamide Derivatives from Arachidonic Acid in the Presence of Boron Catalyst
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Mohammad
      </surname>
      <given-names>
       Al-Masum
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Linda
      </surname>
      <given-names>
       Quinones
      </given-names>
     </name>
    </contrib>
   </contrib-group> 
   <aff id="affnull">
    <addr-line>
     aDepartment of Chemistry, Tennessee State University, Nashville, TN, USA
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     12
    </day> 
    <month>
     10
    </month>
    <year>
     2024
    </year>
   </pub-date> 
   <volume>
    14
   </volume> 
   <issue>
    04
   </issue>
   <fpage>
    128
   </fpage>
   <lpage>
    134
   </lpage>
   <history>
    <date date-type="received">
     <day>
      2,
     </day>
     <month>
      December
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="published">
     <day>
      20,
     </day>
     <month>
      December
     </month>
     <year>
      2024
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      20,
     </day>
     <month>
      December
     </month>
     <year>
      2024
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    Anandamide is part of the cannabinoid group and functions as a neurotransmitter. Anandamide plays a role in depression, pain, appetite, memory, and fertility. Since it is well documented that anandamide analog behaves as probes of the cannabinoid receptor, it is of great interest to find a new method of making new series of anandamide derivatives. Dennis Hall and his group recently reported a direct amidation process of carboxylic acid by ortho-iodo boronic acid. Using ortho-iodo boronic acid as a catalyst, we explore the amidation of arachidonic acid under microwave heating and synthesize anandamide derivatives in high yields.
   </abstract>
   <kwd-group> 
    <kwd>
     Anandamide
    </kwd> 
    <kwd>
      Cross-Coupling
    </kwd> 
    <kwd>
      Microwave
    </kwd> 
    <kwd>
      Alcohol Amines
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>
    <xref ref-type="bibr" rid="scirp.138338-"></xref>Anandamide is becoming a well-studied compound due to its numerous functions in the human body. <xref ref-type="bibr" rid="scirp.138338-1">
     [1]
    </xref>-<xref ref-type="bibr" rid="scirp.138338-6">
     [6]
    </xref> Anandamide (shown in <xref ref-type="fig" rid="fig1">
     Figure 1
    </xref>) is a polyunsaturated fatty acid; it functions as a neurotransmitter and is part of the cannabinoid family. Cannabinoids are compounds that bind to cannabinoid receptors, CB<sub>1</sub> and CB<sub>2</sub>. <xref ref-type="bibr" rid="scirp.138338-2">
     [2]
    </xref> CB<sub>1</sub> and CB<sub>2</sub> receptors are G-protein coupled receptors located in the cell membrane, and they can lead to multiple cellular regulations. G-protein coupled receptors are proteins composed of seven transmembrane domains that lead to cell signaling. CB<sub>1</sub> is located throughout the body, but it is mostly abundant in the brain and the central nervous system. It is responsible for appetite, analgesia, and many other effects. CB<sub>2</sub> is located primarily in the immune system, and it plays a role in anti-inflammatory and immunosuppressive activities.</p>
   <fig id="fig1" position="float">
    <label>Figure 1</label>
    <caption>
     <title>Figure 1. Anandamide.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/1020880-rId17.jpeg?20241223022944" />
   </fig>
   <p>Anandamide binds and activates both CB<sub>1</sub> and CB<sub>2</sub> receptors, but it’s known to primarily bind to CB<sub>1</sub> receptor. Consequently, anandamide plays a role in many aspects of the human body including depression, pain, appetite, memory, and fertility. Furthermore, anandamide has been shown to influence neurodegenerative diseases including analgesia, anxiety, epilepsy, cancer, and Alzheimer’s disease. Since the discovery of arachidonic acid in 1992, its under-study has come a long way. Like ∆<sup>9</sup>-tetrahydrocannabinol (∆<sup>9</sup>-THC) in marihuana, anandamide has similar cannabinoid effects. Anandamide has a faster start and shorter duration compared to ∆<sup>9</sup>-THC in pharmacological tests of analgesia, catalepsy, hypoactivity and hypothermia. Thus making anandamide a perfect example for pharmacological studies.</p>
   <p>We used arachidonic acid and different alcohol amines to synthesize anandamide derivatives. Arachidonic acid (shown in <xref ref-type="fig" rid="fig2">
     Figure 2
    </xref>) is a polyunsaturated fatty acid essential to the human body. Arachidonic acid can be synthesized by the human body from linoleic acid. It can also be indigested by the human body through food intake, like milk. Arachidonic acid is found on cell membranes and it composes some of the phospholipids located in the cell membrane. Arachidonic acid has many functions; for example, it’s needed for the growth and repair of skeletal muscle tissues. Thus, it plays an important role in cell regulation. In 2012, Denis Hall and his group synthesized a new catalyst, 5-methoxy-2-iodo phenylboronic acid (<xref ref-type="fig" rid="fig3">
     Figure 3
    </xref>), which they applied for direct amidation. <xref ref-type="bibr" rid="scirp.138338-7">
     [7]
    </xref>-<xref ref-type="bibr" rid="scirp.138338-9">
     [9]
    </xref></p>
   <fig id="fig2" position="float">
    <label>Figure 2</label>
    <caption>
     <title>Figure 2. Arachidonic acid.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/1020880-rId18.jpeg?20241223022944" />
   </fig>
   <fig id="fig3" position="float">
    <label>Figure 3</label>
    <caption>
     <title>Figure 3. 2-iodo-5-methoxyphenylboronic acid catalyst.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/1020880-rId19.jpeg?20241223022944" />
   </fig>
  </sec><sec id="s2">
   <title>2. Results and Discussion</title>
   <p>We were able to successfully synthesize various amide products from simple carboxylic acids and alcohol amines. Using Hall’s catalyst and our newly developed procedure with microwave heating, we were able to run direct amidation reactions, as shown in <xref ref-type="bibr" rid="scirp.138338-#s1">
     Scheme 1
    </xref>. The reaction procedure of compound 3a is a representative one.</p>
   <fig id="fig4" position="float">
    <label>Figure 4</label>
    <caption>
     <title><sup>a</sup>All products are purified by silica gel chromatography.Scheme 1. Reaction of carboxvlic acids and alcohol amines.<sup>a</sup>We proceeded to synthesize anandamide derivatives. Using this new method that we came up with, we were able to synthesize anandamide derivatives using arachidonic acid and alcohol amines (<xref ref-type="bibr" rid="scirp.138338-#s2">
       Scheme 2
      </xref>).<xref ref-type="bibr" rid="scirp.138338-"></xref><p class="imgGroupCss_v"><img class=" imgMarkCss lazy" data-original="https://html.scirp.org/file/1020880-rId21.jpeg?20241223022944" /></p>Scheme 2. Anandamide derivatives from arachidonic acid and alcohol amines.3. Materials and MethodsAmide and anandamide derivatives were synthesized using iodo-boron catalyst and Denis Hall’s method for direct amidation. The iodo-boron catalyst was synthesized following the published procedure. Then, we synthesized different amide derivatives to test the best method for amidation using microwave heating. After the optimized method under the microwave, we applied the method for synthesizing anandamide derivatives.Synthesis of Compound 3aIn a microwave reaction vial, the catalyst 2-iodo-5-methoxyphenylboronic acid 29.0 mg (20 mol%) was added with hexanoic acid 65 µl (1.1 eq), mol. Sieves (100 mg) and toluene (200 µl) it was then mixed for 10 min. After the 10 min, 2-(methylamino) ethanol 40 µl (1 equiv) was added and mixed. The microwave test tube was then put into the microwave for 30 min at 120˚C. The product was then transferred to a round flask using methanol and then silica gel. It was then evaporated to dry until powder was formed. After evaporation, the product was added to the column chromatography. It was separated catalyst using silica gel and the mixture of hexane and ether acetate in a 25:1 ratio. Once the catalyst was separated from the product, the column was washed with 100 ml of methanol and the product was collected. The purity of the product was tested using CG-MS, <sup>1</sup>H NMR, and <sup>13</sup>C NMR. LRMS: Calculated for C<sub>9</sub>H<sub>20</sub>NO<sub>2</sub> M<sup>+</sup> 174. Found: 174. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 4.2 (s, H, OH), 3.8 (t, 2H, CH<sub>2</sub>), 3.0 (t, 2H, CH<sub>2</sub>), 2.3 (s, 3H, CH<sub>3</sub>), 2.1 (t, 2H, CH<sub>2</sub>), 1.6 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 0.9 (t, 3H, CH<sub>3</sub>); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 207.1, 61.8, 51.6, 31.6, 31.2, 30.99, 24.4, 22.3, 13.9.Synthesis of compound 3h</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/1020880-rId20.jpeg?20241223022944" />
   </fig>
   <p>In a microwave reaction vial, the catalyst 2-iodo-5-methoxyphenylboronic acid 62 mg (0.1 mmol, 20 mol %) was added with arachidonic acid 404 µl (1.1 mmol, 1.1 eq), mol. Sieves (200 mg) and toluene (400 µl) it was then mixed for 10 min. After the 10 min, the 2-(methylamino) ethanol 80 µl (1 mmol, 1 equiv) was added and mixed. The microwave test tube was then put into the microwave for 30 min at 120˚C. The product was then transferred to a round flask using methanol and then silica gel. It was then evaporated to dry until powder was formed. After evaporation, the product was added to the column chromatography. It was separated catalyst using silica gel and the mixture of hexane and ether acetate in a 25:1 ratio. Once the catalyst was separated from the product, the column was washed with 200 ml of methanol and the product was collected. The purity of the product was tested using CG-MS, <sup>1</sup>H NMR, and <sup>13</sup>C NMR. LRMS: Calculated for C<sub>23</sub>H<sub>39</sub>NO<sub>2</sub> M<sup>+</sup> 361. Found: 361. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 5.6 (m, H, CH), 5.6 (m, H, CH), 5.3 (m, H, CH), 5.3 (m, H, CH), 5.3 (m, H, CH), 5.3 (m, H, CH), 3.8 (m, H, CH), 3.8 (m, H, CH), 3.5 (m, 2H, CH<sub>2</sub>), 3.4 (t, 2H, CH<sub>2</sub>), 2.9 (t, H, OH), 2.8 (t, 2H, CH<sub>2</sub>), 2.8 (t, 2H, CH<sub>2</sub>), 2.8 (t, 2H, CH<sub>2</sub>), 2.3 (m, 2H, CH<sub>2</sub>), 2.0 (m, 2H, CH<sub>2</sub>), 2.0 (m, 2H, CH<sub>2</sub>), 1.7 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 0.9 (t, 3H, CH<sub>3</sub>).</p>
   <p>Compound 3i</p>
   <p>LRMS: Calculated for C<sub>24</sub>H<sub>40</sub>NO<sub>2</sub> M<sup>+</sup> 374. Found: 374. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 5.7 (m, H, CH), 5.7 (m, H, CH), 5.3 (m, H, CH), 5.3 (m, H, CH), 5.3 (m, H, CH), 5.3 (m, H, CH), 3.6 (m, H, CH), 3.6 (m, H, CH), 3.5 (m, 2H, CH<sub>2</sub>), 3.2 (t, 2H, CH<sub>2</sub>), 2.9 (t, H, OH), 2.8 (t, 2H, CH<sub>2</sub>), 2.8 (t, 2H, CH<sub>2</sub>), 2.8 (t, 2H, CH<sub>2</sub>), 2.2 (t, 2H, CH<sub>2</sub>), 2.0 (t, 2H, CH<sub>2</sub>), 1.8 (m, 2H, CH<sub>2</sub>), 1.8 (m, 2H, CH<sub>2</sub>), 1.8 (m, 2H, CH<sub>2</sub>), 1.6 (m, 2H, CH<sub>2</sub>), 1.6 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 0.9 (t, 3H,CH<sub>3</sub>).</p>
   <p>Compound 3j</p>
   <p>LRMS: Calculated for C<sub>22</sub>H<sub>37</sub>NO<sub>2</sub> M<sup>+</sup> 347. Found: 347. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 6.0 (m, H, CH), 5.5 (m, H, CH), 5.3 (m, H, CH), 5.3 (m, H, CH), 5.3 (m, H, CH), 5.3 (m, H, CH), 3.8 (m, H, CH), 3.8 (m, H, CH), 3.4 (m, 2H, CH<sub>2</sub>), 3.4 (t, 2H, CH<sub>2</sub>), 3.0 (t, H, OH), 2.8 (t, 2H, CH<sub>2</sub>), 2.8 (t, 2H, CH<sub>2</sub>), 2.8 (t, 2H, CH<sub>2</sub>), 2.3 (m, 2H, CH<sub>2</sub>), 2.0 (m, 2H, CH<sub>2</sub>), 2.0 (m, 2H, CH<sub>2</sub>), 1.6 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 0.9 (t, 3H,CH<sub>3</sub>).</p>
   <p>Compound 3k</p>
   <p>LRMS: Calculated for C<sub>25</sub>H<sub>42</sub>NO<sub>2</sub> M<sup>+</sup> 378. Found: 378. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 6.1 (m, H, CH), 6.1 (m, H, CH), 5.4 (m, H, CH), 5.4 (m, H, CH), 5.4 (m, H, CH), 5.4 (m, H, CH), 3.7 (m, H, CH), 3.7 (m, H, CH), 3.6 (m, 2H, CH<sub>2</sub>), 3.6 (t, 2H, CH<sub>2</sub>), 2.9 (t, H, OH), 2.8 (t, 2H, CH<sub>2</sub>), 2.8 (t, 2H, CH<sub>2</sub>), 2.8 (t, 2H, CH<sub>2</sub>), 2.2 (t, 2H, CH<sub>2</sub>), 2.0 (m, 2H, CH<sub>2</sub>), 2.0 (m, 2H, CH<sub>2</sub>), 1.6 (m, 2H, CH<sub>2</sub>), 1.5 (m, 2H, CH<sub>2</sub>), 1.5 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 1.3 (m, 2H, CH<sub>2</sub>), 0.8 (t, 3H,CH<sub>3</sub>).</p>
   <p>Synthesis of 2-iodo-5-methoxyphenylboronic acid (Catalyst)</p>
   <p>In a three-neck round flask, 3-methoxyphenylboronic acid 1.4 g (9.44 mmol, 1 equiv) was added with silver (I) sulfate 1.62 g (5.2 mmol, 0.55 equiv) and ethanol (30 mL) at room temperature under argon<sup>1</sup>. In a two-neck round flask iodine 2.4 g (9.44 mmol, 1 equiv) was added with ethanol (30 mL) and mixed at room temperature until dissolved under argon. <xref ref-type="bibr" rid="scirp.138338-7">
     [7]
    </xref> The iodine mixture was then injected dropwise into the three-neck round flask; it was then mixed for around two hours until a color changed. The resulting mixture was then filtered through a Celite 545 pad, evaporated, and put under vacuum for drying. Before extraction, 50 mL of water was added, and the mixture was extracted with ethyl acetate and brine solution. The collected organic layer in ethyl acetate was treated with anhydrous sodium sulfate for complete dehydration. The sodium sulfate is filtered out by filtration through a sintered funnel under reduced pressure. The synthesized boron catalyst in ethyl acetate was collected by using a rotary evaporator under vacuum. The crude product was then subjected to column chromatography using silica gel and a mixture of hexane and ethyl acetate with a 3:1 ratio as eluents. The catalyst was then tested for purity using GC-MS and NMR.</p>
  </sec><sec id="s3">
   <title>4. Conclusion</title>
   <p>We were able to establish an optimum synthetic method for the direct amidation of simple carboxylic acids with alcohol amines in the presence of metal-free boron catalyst. Following the same reaction conditions, we were also able to synthesize anandamide derivatives from arachidonic acid. We tried Denis Hall’s separation method for direct amidation: filtration through a Celite 545 pad, then separation with pH 3, pH 11, brine (NaCl) solution and sodium sulfate for removing water. <xref ref-type="bibr" rid="scirp.138338-7">
     [7]
    </xref> His method for separation didn’t work for our compounds. Then we tried filtration with Celite 545 pad, then separation with ethyl acetate brine solution and sodium sulfate to remove water. This method for separation didn’t work as well. We then went for column chromatography, where we used alumina with hexane and ethyl acetate with a 2 to 1 ratio, which didn’t work. Also, we went for the column with silica gel instead of hexane only, which didn’t work. Column with silica gel with hexane and ethyl acetate 1 to 1 ratio didn’t work. Finally, we went for a column with silica gel with hexane and ethyl acetate 25 to 1 ratio, which only separated the catalyst from the product. Thus, then we used a washing method, where you poured methanol as eluent and collected the product with methanol.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.138338-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kozak, K.R., Prusakiewicz, J.J., Rowlinson, S.W., Prudhomme, D.R. and Marnett, L.J. (2003) Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid Anandamide. Biochemistry, 42, 9041-9049. &gt;https://doi.org/10.1021/bi034471k
    </mixed-citation>
   </ref>
   <ref id="scirp.138338-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Dossou, K.S.S., Devkota, K.P., Morton, C., Egan, J.M., Lu, G., Beutler, J.A., et al. (2013) Identification of CB1/CB2 Ligands from Zanthoxylum bungeanum. Journal of Natural Products, 76, 2060-2064. &gt;https://doi.org/10.1021/np400478c
    </mixed-citation>
   </ref>
   <ref id="scirp.138338-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Elsebai, M.F., Rempel, V., Schnakenburg, G., Kehraus, S., Müller, C.E. and König, G.M. (2011) Identification of a Potent and Selective Cannabinoid CB1 Receptor Antagonist from Auxarthron reticulatum. ACS Medicinal Chemistry Letters, 2, 866-869. &gt;https://doi.org/10.1021/ml200183z
    </mixed-citation>
   </ref>
   <ref id="scirp.138338-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Fulp, A., Bortoff, K., Zhang, Y., Snyder, R., Fennell, T., Marusich, J.A., et al. (2013) Peripherally Selective Diphenyl Purine Antagonist of the CB1 Receptor. Journal of Medicinal Chemistry, 56, 8066-8072. &gt;https://doi.org/10.1021/jm401129n
    </mixed-citation>
   </ref>
   <ref id="scirp.138338-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Palermo, G., Campomanes, P., Cavalli, A., Rothlisberger, U. and De Vivo, M. (2014) Anandamide Hydrolysis in FAAH Reveals a Dual Strategy for Efficient Enzyme-Assisted Amide Bond Cleavage via Nitrogen Inversion. The Journal of Physical Chemistry B, 119, 789-801. &gt;https://doi.org/10.1021/jp5052276
    </mixed-citation>
   </ref>
   <ref id="scirp.138338-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ahn, K., McKinney, M.K. and Cravatt, B.F. (2008) Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous System. Chemical Reviews, 108, 1687-1707. &gt;https://doi.org/10.1021/cr0782067
    </mixed-citation>
   </ref>
   <ref id="scirp.138338-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gernigon, N., Al-Zoubi, R.M. and Hall, D.G. (2012) Direct Amidation of Carboxylic Acids Catalyzed by Ortho-Iodo Arylboronic Acids: Catalyst Optimization, Scope, and Preliminary Mechanistic Study Supporting a Peculiar Halogen Acceleration Effect. The Journal of Organic Chemistry, 77, 8386-8400. &gt;https://doi.org/10.1021/jo3013258
    </mixed-citation>
   </ref>
   <ref id="scirp.138338-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Montalbetti, C.A.G.N. and Falque, V. (2005) Amide Bond Formation and Peptide Coupling. Tetrahedron, 61, 10827-10852. &gt;https://doi.org/10.1016/j.tet.2005.08.031
    </mixed-citation>
   </ref>
   <ref id="scirp.138338-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Valeur, E. and Bradley, M. (2009) Amide Bond Formation: Beyond the Myth of Coupling Reagents. Chemical Society Reviews, 38, 606-631. &gt;https://doi.org/10.1039/b701677h
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>